Harte-Hanks's common stock is $12M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (June 2026), HHS shows a common stock of $12M. That compares with $12M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HHS's common stock is now $12M (was $12M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Harte-Hanks is outperforming or lagging.
Tracking HHS's common stock over time shows whether Harte-Hanks is scaling, shrinking, or reshaping that part of the business. The current reading is $12M That compares with $12M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Harte-Hanks's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $12M) with ownership activity and broader fundamentals.
Harte-Hanks's common stock is $12M; compare it with other Consumer Discretionary names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.